Re-Stem Biotech is a biotechnology firm engaged in the research and development of cell based therapies and products. Backed by state of the art GMP facilities and an international team of world-leading scientists, doctors and management team, Re-Stem currently has a robust technology platform including three profitable therapies on the market and eight other therapy/ products in the pipeline. Incorporated in 2012 with headquarter in Suzhou, China, and clinical labs in Shenzhen, Ganzhou, Beijing, and Suzhou. To learn more about Re-Stem, please visit www.restembiotech.com